Oncodesign Services Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 220

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Financing Rounds
  • 8

  • Investments
  • 3

Oncodesign Services General Information

Description

Developer of drug discovery and preclinical research services system intended for pharmaceutical and biotech companies. The company's platform offers integrated capabilities across medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vitro/in vivo pharmacology, enabling global life science clients to advance small molecules, biologics, and radiotherapeutic candidates from target validation to IND filing.

Contact Information

Formerly Known As
Oncodesign, Oncodesign S.A.
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 20 Rue Jean Mazen
  • 21000 Dijon
  • France
+33 03
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 20 Rue Jean Mazen
  • 21000 Dijon
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncodesign Services Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncodesign Services‘s full profile, request access.

Request a free trial

Oncodesign Services Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug discovery and preclinical research services system intended for pharmaceutical and biotech companies.
Drug Discovery
Dijon, France
220 As of 2025

Nottingham, United Kingdom
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncodesign Services Competitors (37)

One of Oncodesign Services’s 37 competitors is Sygnature Discovery, a Private Equity-Backed company based in Nottingham, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
BPS Bioscience Corporation San Diego, CA
PEP-Therapy Venture Capital-Backed Evry Cedex, France
MaaT Pharma Formerly VC-backed Lyon, France
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 37 competitors. Get the full list »

Oncodesign Services Patents

Oncodesign Services Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260125383-A1 Indazole inhibitors of cyclic gmp-amp synthase and uses thereof Pending 27-Sep-2023
US-20260125384-A1 Indazole inhibitors of cyclic gmp-amp synthase and uses thereof Pending 27-Sep-2023
WO-2022194976-A1 Macrocyclic lrrk2 kinase inhibitors Inactive 18-Mar-2021
WO-2021224320-A1 New macrocyclic lrrk2 kinase inhibitors Inactive 06-May-2020
US-20260125396-A1 Macrocyclic rip2-kinase inhibitors Pending 31-Jan-2020 C07D498/22
To view Oncodesign Services’s complete patent history, request access »

Oncodesign Services Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncodesign Services Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncodesign Services‘s full profile, request access.

Request a free trial

Oncodesign Services Investments & Acquisitions (3)

Oncodesign Services’s most recent deal was a Buyout/LBO with ZoBio. The deal was made on 22-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ZoBio 22-Jan-2024 Buyout/LBO Drug Discovery
Bertin Pharma (Service Businesses) 31-Aug-2017 Merger/Acquisition Other Pharmaceuticals and Biotechnology
GlaxoSmithKline (Francois Hyafil) 01-Dec-2016 Corporate Asset Purchase Buildings and Property
To view Oncodesign Services’s complete investments and acquisitions history, request access »

Oncodesign Services FAQs

  • When was Oncodesign Services founded?

    Oncodesign Services was founded in 1995.

  • Where is Oncodesign Services headquartered?

    Oncodesign Services is headquartered in Dijon, France.

  • What is the size of Oncodesign Services?

    Oncodesign Services has 220 total employees.

  • What industry is Oncodesign Services in?

    Oncodesign Services’s primary industry is Drug Discovery.

  • Is Oncodesign Services a private or public company?

    Oncodesign Services is a Private company.

  • What is Oncodesign Services’s current revenue?

    The current revenue for Oncodesign Services is .

  • How much funding has Oncodesign Services raised over time?

    Oncodesign Services has raised $23.8M.

  • Who are Oncodesign Services’s investors?

    Eurazeo, Edmond de Rothschild Group, Elyan Partners, and LINK-J have invested in Oncodesign Services.

  • Who are Oncodesign Services’s competitors?

    Sygnature Discovery, BPS Bioscience, PEP-Therapy, MaaT Pharma, and Vedanta Biosciences are some of the 37 competitors of Oncodesign Services.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process